Standard therapy for heart failure

DRUG2 trials

Sponsors

Corimmun GmbH, Carmat SAS

Conditions

Advanced Heart FailureCardiomyopathy, Dilated

Phase 2

Pilot Study of COR-1 in Heart Failure

CompletedNCT01391507

Corimmun GmbHCardiomyopathy, Dilated

Start: 2011-10-31End: 2013-08-31Updated: 2014-10-17

Unknown Phase

Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure

Active, not recruitingNCT04475393

Carmat SASAdvanced Heart Failure

Start: 2022-12-12End: 2027-04-01Target: 104Updated: 2026-04-28